New research reveals challenges and missed opportunities for wearables in clinical trials
(c)iStock.com/Sezeryadigar
A ‘significant’ number of biopharma companies are not actively incorporating wearable technology into their clinical trials, according to a new study from the Life Science Strategy Group, which argues there is a missed opportunity.
The report focuses on adoption of wearable technology in clinical trials and perceived preparedness of contract research organisations (CROs) to include wearable technology into clinical development services. Quantitative research with nearly...